Skip to main navigation
Skip to search
Skip to main content
Scholars @ UT Health San Antonio Home
Help & FAQ
English
Español
Home
Profiles
Research units
Publications
Datasets
Search by expertise, name or affiliation
Lorcaserin Use in the Management of Morbid Obesity in a Pre-Liver Transplant Patient
Julio A. Gutierrez
, Carmen Landaverde
, Jennifer T. Wells
,
Fred Poordad
UT Health San Antonio Transplant Center
Division of Gastroenterology
Research output
:
Contribution to journal
›
Article
›
peer-review
4
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Lorcaserin Use in the Management of Morbid Obesity in a Pre-Liver Transplant Patient'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Liver Transplantation
100%
Lorcaserin
100%
Decompensated Liver Cirrhosis
66%
Weight Loss
66%
Complication
33%
Transplantation
33%
Body Mass Index
33%
Obesity
33%
Portal Hypertension
33%
Hepatology
33%
Peroperative Complication
33%
Liver Graft
33%
Attributable Risk
33%
Enalapril Maleate
33%
Drug
33%
Chemotherapeutic Agent
33%
Rupture
33%
Patient
33%
Morbid Obesity
33%
Pharmacology, Toxicology and Pharmaceutical Science
Lorcaserin
100%
Decompensated Liver Cirrhosis
66%
Complication
33%
Obesity
33%
Enalapril Maleate
33%
Drug
33%
Morbid Obesity
33%
Portal Hypertension
33%
Peroperative Complication
33%
Rupture
33%